Biodesix GAAP EPS of -$0.08 misses by $0.02, revenue of $18M misses by $3.23M

Stock Information for Biodesix Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Biodesix Inc.

Biodesix Partners with Association of Pulmonary Advanced Practice Providers (APAPP) to Deliver Nation's First Medical Education for APPs on Biomarkers in Lung Nodule and Lung Cancer Programs
Biodesix Announces New Data on the VeriStrat® Test to be Presented at the 2025 ASCO Annual Meeting
Biodesix to Participate in Upcoming Investor Conferences
Biodesix Announces New Clinical and Economic Data for its Nodify Lung® Tests at ISPOR and ATS
Denver Post Names Biodesix a Winner of Top Workplaces 2025 Award
Biodesix Announces First Quarter 2025 Results and Highlights
Biodesix to Report First Quarter 2025 Financial Results on May 13, 2025
Biodesix partner, Friends of Cancer Research, publishes data in Clinical Cancer Research, demonstrating strong association between ctDNA changes and treatment outcomes for patients with solid tumor types

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.